Glen Eagle Advisors, LLC Clear Point Neuro, Inc. Transaction History
Glen Eagle Advisors, LLC
- $546 Billion
- Q2 2024
A detailed history of Glen Eagle Advisors, LLC transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 50 shares of CLPT stock, worth $594. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50Holding current value
$594% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CLPT
# of Institutions
90Shares Held
7.04MCall Options Held
35KPut Options Held
22.8K-
Vanguard Group Inc Valley Forge, PA1.22MShares$14.5 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny465KShares$5.53 Million0.0% of portfolio
-
Essex Investment Management CO LLC Boston, MA463KShares$5.5 Million0.49% of portfolio
-
Taylor Frigon Capital Management LLC425KShares$5.05 Million1.1% of portfolio
-
Cm Management, LLC375KShares$4.46 Million1.88% of portfolio
About ClearPoint Neuro, Inc.
- Ticker CLPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,488,300
- Market Cap $291M
- Description
- ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...